# \[e-drug\] European & Developing Countries Clinical Trials Partnership **URL:** \ **Category:** e-drug\ **Created:** [May 29, 2004, 8:31am UTC](https://talk.edrugplus.org/t/e-drug-european-developing-countries-clinical-trials-partnership/19724 "2004-05-29T08:31:44Z")\ **Posts on this page:** 1\ **Page:** 1
**Author:** ![E-drug](https://avatars.discourse-cdn.com/v4/letter/e/ecd19e/32.png) [@E-drug](https://talk.edrugplus.org/u/E-drug)\ **Post date:** [May 29, 2004, 8:31am UTC](https://talk.edrugplus.org/t/e-drug-european-developing-countries-clinical-trials-partnership/19724/1 "2004-05-29T08:31:44Z")
E-DRUG: European & Developing Countries Clinical Trials Partnership ------------------------------------------------------------------- [African researchers might be interested in this; thanks to Richard Laing for spotting this. WB] The European & Developing Countries Clinical Trials Partnership (EDCTP) Call for Proposals Senior Fellowship Programme Dear Sir, Madam, The EDCTP is an initiative by European Union Member States and Norway to reinforce research into the development of new clinical interventions against HIV/AIDS, tuberculosis and malaria. To this end, a partnership with the developing countries (DCs), in particular in sub-Saharan Africa, has been established. The Partnership Board (PB) consists of 12 European and African scientists who will oversee the scientific aspects. To address the mission of the EDCTP, the focus of supported activities will be on accelerating the clinical evaluation of candidate new interventions, including: conducting controlled trials of the highest quality of new and improved drugs and vaccines against the target diseases, and increasing the capacity of scientists and institutions in the DCs to undertake such trials. EDCTP supported interventions should be made available at a price that allows their widespread use in the DCs. A major objective ensuing from the mission of the EDCTP is to encourage and facilitate networking and coordination of clinical trial activities on the target diseases within Europe and, primarily, sub-Saharan Africa, and importantly between scientists in these two regions. The EDCTP calls for African researchers to react on our Call for Proposals for Senior Fellowships. Through this call, the EDCTP intends to identify and support senior researchers capable of building up teams in African institutions that will be internationally competitive and capable of winning grants from international funding bodies for research on the three major poverty-related diseases in Africa (HIV/AIDS, tuberculosis and malaria). The EDCTP Fellow will undertake applied research in clinical trials related disciplines such as epidemiology, clinical medicine, virology, immunology, parasitology, pharmacology and molecular biology. The deadline for receipt of completed applications is 25 June2004. For more information on this call and form of application, I kindly refer you to our web site: [http://www.edctp.org](http://www.edctp.org) Would you be kind to distribute this e-mail within your own organisation and amongst interesting parties as appropriate? Kind regards, Dr. P. Olliaro Executive Director EDCTP Ms. Katalijne van Diest, MSc Programme Coordinator EDCTP - European & Developing Countries Clinical Trials Partnership 334 Laan van Nieuw Oost Indi� P.O. Box 93015, 2509 AA The Hague, The Netherlands Phone: +31 (0)70 344 08 91 Fax: +31 (0)70 344 08 99 E-mail: diest@edctp.org Website: www.edctp.org [some attachments could not be transmitted over the E-drug network; download them from the EDCTP website: [http://www.edctp.org/3\_calls.htm\](http://www.edctp.org/3_calls.htm%5C)] -- To send a message to E-Drug, write to: e-drug@healthnet.org To subscribe or unsubscribe, write to: majordomo@healthnet.org in the body of the message type: subscribe e-drug OR unsubscribe e-drug To contact a person, send a message to: e-drug-help@healthnet.org Information and archives: [http://www.essentialdrugs.org/edrug](http://www.essentialdrugs.org/edrug)